marco bregni
marco bregni
azienda ospedaliera busto arsizio
Verified email at - Homepage
TitleCited byYear
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells
R Dalla-Favera, M Bregni, J Erikson, D Patterson, RC Gallo, CM Croce
Proceedings of the National Academy of Sciences 79 (24), 7824-7827, 1982
Gene therapy for immunodeficiency due to adenosine deaminase deficiency
A Aiuti, F Cattaneo, S Galimberti, U Benninghoff, B Cassani, L Callegaro, ...
New England Journal of Medicine 360 (5), 447-458, 2009
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation
AM Gianni, M Bregni, AC Stern, S Siena, C Tarella, A Pileri, G Bonadonna
The Lancet 334 (8663), 580-585, 1989
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients
S Siena, M Bregni, B Brando, N Belli, F Ravagnani, L Gandola, AC Stern, ...
Blood 77 (2), 400-409, 1991
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma
AM Gianni, M Bregni, S Siena, C Brambilla, M Di Nicola, F Lombardi, ...
New England Journal of Medicine 336 (18), 1290-1298, 1997
Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte …
S Siena, M Bregni, B Brando, F Ravagnani, G Bonadonna, AM Gianni
Blood 74 (6), 1905-1914, 1989
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase …
F Ciceri, C Bonini, MTL Stanghellini, A Bondanza, C Traversari, ...
The lancet oncology 10 (5), 489-500, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
P Ljungman, M Bregni, M Brune, J Cornelissen, T De Witte, G Dini, ...
Bone marrow transplantation 45 (2), 219, 2010
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic …
P Corradini, A Dodero, F Zallio, D Caracciolo, M Casini, M Bregni, F Narni, ...
Journal of Clinical Oncology 22 (11), 2172-2176, 2004
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.
S Siena, MN Di, M Bregni, R Mortarini, A Anichini, L Lombardi, ...
Experimental hematology 23 (14), 1463-1471, 1995
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer
M Bregni, A Dodero, J Peccatori, A Pescarollo, M Bernardi, I Sassi, ...
Blood 99 (11), 4234-4236, 2002
The EBMT activity survey: 1990–2010
JR Passweg, H Baldomero, A Gratwohl, M Bregni, S Cesaro, P Dreger, ...
Bone marrow transplantation 47 (7), 906, 2012
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year …
AM Gianni, S Siena, M Bregni, M Di Nicola, S Orefice, F Cusumano, ...
Journal of clinical oncology 15 (6), 2312-2321, 1997
Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
EJ Villablanca, L Raccosta, D Zhou, R Fontana, D Maggioni, A Negro, ...
Nature medicine 16 (1), 98, 2010
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in …
AM Gianni, M Bregni, S Siena, A Orazi, AC Stern, L Gandola, ...
Journal of Clinical Oncology 8 (5), 768-778, 1990
A proportion of patients with lymphoma may harbor mutations of the perforin gene
R Clementi, F Locatelli, L Dupré, A Garaventa, L Emmi, M Bregni, ...
Blood 105 (11), 4424-4428, 2005
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies
P Corradini, C Tarella, A Olivieri, AM Gianni, C Voena, F Zallio, M Ladetto, ...
Blood 99 (1), 75-82, 2002
Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation
F Ciceri, C Bonini, S Marktel, E Zappone, P Servida, M Bernardi, ...
Blood 109 (11), 4698-4707, 2007
Safety of retroviral gene marking with a truncated NGF receptor
C Bonini, M Grez, C Traversari, F Ciceri, S Marktel, G Ferrari, M Dinauer, ...
Nature medicine 9 (4), 367, 2003
Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo‐radiotherapy?
AM Gianni, M Bregni, S Siena, S Villa, GA Sciorelli, F Ravagnani, ...
Hematological oncology 7 (2), 139-148, 1989
The system can't perform the operation now. Try again later.
Articles 1–20